Zacks Investment Research
22 Jan 2026, 18:31 UTC · 42w ago
Medifast's Q4 Guidance Remains Weak: When Does Growth Return?
Verdict
Headline takes no side. We score MED −0.80 — strongly bearish.
- Expected · MED
−0.80strongly bearish
−1 bearish0bullish +1More negative than 92% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.

Search tags




